항암치료에서 약사처방중재의 경제적 편익분석

• 영문명: Assessment of Economic Benefit of Clinical Pharmacy Services in Oncology
• 발행기관: 대한약학회
• 저자명: 김귀숙(Kwi Suk Kim) 서성연(Sung Yun Suh) 임정미(Jung Mi Lim) 이주연(Juyeun Lee) 고영일(Youngil Koh) 서혜선(Hae Sun Suh)
• 간행물 정보: 『약학회지』제64권 제3호(2020년), 219~225쪽, 전체 7쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2020.06.30

영문 초록

This study analyzed the economic benefits of pharmacists’ prescription intervention in appropriate chemotherapeutic efficacy and safety. We analyzed the types of prescription interventions and the severities of prescription errors by reviewing electronic medical record and intervention reports for anticancer patients from May 1st 2013 through December 31st 2014. Total of 114,536 prescriptions were reviewed during the study period and 3,305 (2.9%) prescription interventions were conducted. The evaluation of the economic values for prescription arbitration was calculated by the amount of prevention of drug loss, the risk avoidance cost against inappropriate prescriptions, and the cost of preventing unnecessary preparations. The labor cost of pharmacists for prescription interventions was 15,758,479 won. When we estimated the savings due to pharmacist’s prescription intervention, the cost of risk avoidance of using the Probability of Harm (POH) resulted from inappropriate prescriptions was estimated to be 2,514,652,575 won. The prevention cost of loss was 586,560,148 won, whereas reduction cost of the unnecessary preparation was 3,944,242 won. Consequently, the net benefit of clinical pharmacy services in oncology during 20 months was estimated to be 3,089,398,486 won when we used the method of POH. Overall, the pharmacist’s prescription arbitration appeared to be beneficial not only for the patient’s safety but also for the economic benefits.

목차

서 론(Introduction)

연구 방법(Research Methods)

결과 및 고찰(Results and Discussion)

결 론(Conclusion)

감사의 말씀(Acknowledgment)

Conflict of Interest

References

키워드

oncology service hospital pharmacists cost-benefit analysis economic pharmaceutical